Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$158K Buy
9,880
+1,122
+13% +$22.7K ﹤0.01% 5445
2014
Q2
$211K Buy
8,758
+6,719
+330% +$157K ﹤0.01% 5092
2014
Q1
$46K Buy
2,039
+1,566
+331% +$34.1K ﹤0.01% 6955
2013
Q4
$10K Sell
473
-1,561
-77% -$32.5K ﹤0.01% 8975
2013
Q3
$63K Buy
2,034
+1,561
+330% +$50K ﹤0.01% 6558
2013
Q2
$12K Buy
+473
New +$12.7K ﹤0.01% 8439

Other funds holding LRN

UBS's LRN Position: Q3 2014 in Review

UBS increased its Stride (LRN) stake by 13% in Q3 2014, buying an estimated $22.7K and bringing the position to 9,880 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #5445.

UBS first reported a position in LRN in Q2 2013 and has held it in 6 quarters since. The position peaked at $211K in Q2 2014. 140 funds tracked by Wall St. Rank hold LRN as of Q3 2014.

  • UBS held 9,880 shares of Stride worth $158K as of Q3 2014.
  • UBS bought 1,122 Stride shares in Q3 2014, an estimated $22.7K.
  • Stride made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5445 holding.
  • UBS first reported a position in Stride in Q2 2013 and has held it in 6 quarters since.
  • UBS's Stride position peaked at $211K in Q2 2014.
  • 140 funds tracked by Wall St. Rank held Stride as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.